Ethics and Drug Resistance: Collective Responsibility for Global Public Health

Front Cover
Euzebiusz Jamrozik, Michael Selgelid
Springer Nature, Oct 26, 2020 - Philosophy - 448 pages

This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.


 

Contents

Collective Responsibility for Global Public Health Chapter 1 DrugResistant Infection Causes Consequences and Responses
3
Collective Responsibility for Global Public Health Chapter 2 Preventive Therapy for Multidrug Resistant Latent Tuberculosis Infection An Ethical Im...
19
Collective Responsibility for Global Public Health Chapter 3 Providing Universal Access While Avoiding Antiretroviral Resistance Ethical Tensions i...
37
Collective Responsibility for Global Public Health Chapter 4 Ethics and Antimalarial Drug Resistance
55
Collective Responsibility for Global Public Health Chapter 5 Antimicrobial Resistance and the Private Sector in Southeast Asia
74
Collective Responsibility for Global Public Health Chapter 6 Hospital Infection Prevention and Control IPC and Antimicrobial Stewardship AMS Dua...
89
Collective Responsibility for Global Public Health Chapter 7 Epidemiology and Ethics of Antimicrobial Resistance in Animals
109
Collective Responsibility for Global Public Health Part II Theoretical Approaches to Ethics and Drug Resistance
122
Collective Responsibility for Global Public Health Chapter 15 Fairness in the Use of Information About Carriers of Resistant Infections
243
Collective Responsibility for Global Public Health Chapter 16 Antimicrobial Resistance and Social Inequalities in Health Considerations of Justice
257
Collective Responsibility for Global Public Health Chapter 17 The Economics of Resistance Through an Ethical Lens
279
Collective Responsibility for Global Public Health Part III Ethics Regulation Governance and Drug Resistance
295
Collective Responsibility for Global Public Health Chapter 18 Antibiotics and Animal Agriculture The Need for Global Collective Action
296
Collective Responsibility for Global Public Health Chapter 19 Technological Fixes and Antimicrobial Resistance
309
Collective Responsibility for Global Public Health Chapter 20 Tackling Antimicrobial Resistance An Ethical Framework for Rational Antibiotic Use
321
Collective Responsibility for Global Public Health Chapter 21 Solidarity and Antimicrobial Resistance
345

Collective Responsibility for Global Public Health Chapter 8 The Virtuous Physician and Antimicrobial Prescribing Policy and Practice
125
Collective Responsibility for Global Public Health Chapter 9 Moral Responsibility and the Justification of Policies to Preserve Antimicrobial Effective...
141
Collective Responsibility for Global Public Health Chapter 10 Access to Effective Diagnosis and Treatment for DrugResistant Tuberculosis Deepenin...
155
Collective Responsibility for Global Public Health Chapter 11 The Right to Refuse Treatment for Infectious Disease
170
Collective Responsibility for Global Public Health Chapter 12 Surveillance and Control of Asymptomatic Carriers of DrugResistant Bacteria
183
Collective Responsibility for Global Public Health Chapter 13 Conceptualizing the Impact of MDRO Control Measures Directed at Carriers A Capabili...
203
Collective Responsibility for Global Public Health Chapter 14 A Capability Perspective on Antibiotic Resistance Inequality and Child Development
225
Collective Responsibility for Global Public Health Chapter 22 Justifying Antibiotic Resistance Interventions Uncertainty Precaution and Ethics
357
Collective Responsibility for Global Public Health Chapter 23 Antimicrobial Footprints Fairness and Collective Harm
376
Collective Responsibility for Global Public Health Chapter 24 Global Health Governance and Antimicrobial Resistance
389
Collective Responsibility for Global Public Health Chapter 25 Global Governance of Antimicrobial Resistance A Legal and Regulatory Toolkit
400
Collective Responsibility for Global Public Health Chapter 26 The SuperWicked Problem of Antimicrobial Resistance
421
Collective Responsibility for Global Public Health Index
445
Copyright

Other editions - View all

Common terms and phrases

About the author (2020)

Doctor Euzebiusz Jamrozik is a practising physician and bioethics PhD candidate in the Monash Bioethics Centre at Monash University, where he also completed an MA in Bioethics after prior studies in medicine and philosophy at University of Western Australia. His multidisciplinary interests include infectious disease, public health ethics, and epidemiology. Among other topics, his recent publications focus on ethical implications of vaccination, vector-borne disease, human challenge studies, and climate change impact on infectious disease. He is a Fellow of the Royal Australasian College of Physicians (FRACP) and Member of the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University.

Professor Michael Selgelid is Director of the Monash Bioethics Centre and the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University in Melbourne, Australia. His research primarily focuses on public health ethics, infectious disease ethics, research ethics, and ethical issues associated with biotechnology and other emerging technologies. He edits a book series in Public Health Ethics Analysis for Springer and is Co-Editor of Monash Bioethics Review. Michael earned a BS in Biomedical Engineering from Duke University and a PhD in Philosophy from the University of California, San Diego.

Bibliographic information